Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.40 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.34 |
| ▸ | CA12 | O43570 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | CA1 | P00915 | 1/20 | 0.31 |
| ▸ | CA2 | P00918 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19492 | 0.83 | SMN1; SMN2 (0.48) | SMN1; SMN2CA14CA12KMT2AALDH1A1 | |
| SCHEMBL7638966 | 0.82 | SMN1; SMN2 (0.41) | SMN1; SMN2CA14CA12KMT2AALDH1A1 | |
| SCHEMBL237982 | 0.77 | — | — | |
| SCHEMBL28156637 | 0.77 | SMN1; SMN2 (0.48) | SMN1; SMN2CA14CA12KMT2AALDH1A1 | |
| SCHEMBL5076701 | 0.77 | SMN1; SMN2 (0.41) | SMN1; SMN2CA14CA12KMT2AALDH1A1 | |
| SCHEMBL224303 | 0.76 | — | — | |
| SCHEMBL353238 | 0.76 | — | — | |
| SCHEMBL457732 | 0.75 | ALDH1A1 (0.42) | KMT2AALDH1A1 | |
| SCHEMBL6323020 | 0.75 | TSHR (0.40) | — | |
| SCHEMBL8355254 | 0.75 | SMN1; SMN2 (0.37) | SMN1; SMN2CA14CA12KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 198 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025110550-A1 | COMPLEX FOR GENE DELIVERY | 전남대학교산학협력단 | 2025-05-30 | — | — | WO | claimed |
| CN-116632340-A | Lithium ion electrolyte for inhibiting flatulence, preparation method thereof and electrochemical device | 湖南法恩莱特新能源科技有限公司 | 2023-08-22 | — | — | CN | claimed |
| EP-0135491-B1 | HERBICIDAL 2,6-BIS-FLUOROMETHYL-DIHYDROPYRIDINE-3,5-DICARBOXYLIC ACID ESTERS | MONSANTO COMPANY (US) | 1989-01-25 | — | — | EP | claimed |
| EP-0135491-A1 | Herbicidal 2,6-bis-fluoromethyl-dihydropyridine-3,5-dicarboxylic acid esters | MONSANTO COMPANY (US) | 1985-03-27 | — | — | EP | claimed |
| JP-9227440-A | — | — | None | — | — | JP | disclosed |
| US-12544382-B2 | 2, 4, 6-tri-substituted pyrimidine compound as ATR kinase inhibitor | BEIJING TIDE PHARMACEUTICAL CO., LTD. (CN) | 2026-02-10 | — | — | US | disclosed |
| WO-2025110550-A1 | COMPLEX FOR GENE DELIVERY | 전남대학교산학협력단 | 2025-05-30 | — | — | WO | disclosed |
| CN-118908902-A | Preparation method of 3-trifluoromethyl-2-pyrazinecarboxylic acid ester compound | 山东京博农化科技股份有限公司 | 2024-11-08 | — | — | CN | disclosed |
| CN-118619944-A | 2,4, 6-Trisubstituted pyrimidine compounds as ATR kinase inhibitors | 北京泰德制药股份有限公司 | 2024-09-10 | — | — | CN | disclosed |
| CN-118355007-A | Herbicidal pyridone derivatives | 先正达农作物保护股份公司 | 2024-07-16 | — | — | CN | disclosed |
| CN-114555720-B | Antifouling additive | 阿萨达股份公司 | 2024-04-05 | — | — | CN | disclosed |
| US-20240043593-A1 | Fluorine-Containing Polymer | CENTRAL GLASS COMPANY, LIMITED (JP) | 2024-02-08 | — | — | US | disclosed |
| US-4826532-A | HERBICIDES | MONSANTO COMPANY (US) | 1989-05-02 | — | — | US | disclosed |
| EP-0135491-B1 | HERBICIDAL 2,6-BIS-FLUOROMETHYL-DIHYDROPYRIDINE-3,5-DICARBOXYLIC ACID ESTERS | MONSANTO COMPANY (US) | 1989-01-25 | — | — | EP | disclosed |
| EP-0278944-A1 | Substituted 2,6-substituted pyridine compounds | Monsanto Company (US) | 1988-08-17 | — | — | EP | disclosed |
| EP-0278945-A2 | Substituted 2,6-substituted pyridine compounds | Monsanto Company (US) | 1988-08-17 | — | — | EP | disclosed |
| US-4692184-A | HERBICIDES | MONSANTO COMPANY (US) | 1987-09-08 | — | — | US | disclosed |
| EP-0135491-A1 | Herbicidal 2,6-bis-fluoromethyl-dihydropyridine-3,5-dicarboxylic acid esters | MONSANTO COMPANY (US) | 1985-03-27 | — | — | EP | disclosed |
| EP-0133612-A2 | Substituted 2,6-substituted pyridine compounds | MONSANTO COMPANY (US) | 1985-02-27 | — | — | EP | disclosed |
| US-4042603-A | SUBSTITUTED DIBENZOFURAN OR 9-FLUORENONE FROM A DIPHENYL ETHER OR BENZOPHENONE | UBE INDUSTRIES, LTD. (JA) | 1977-08-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12544382-B2 | 2, 4, 6-tri-substituted pyrimidine compound as ATR kinase inhibitor | ATR, CHEK1, CHEK2 | SMN1; SMN2 1690/4885CA14 4044/4885CA12 3912/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.